Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch :
Am J Nurs. 2021 May 1;121(5):24-25. doi: 10.1097/01.NAJ.0000751096.82989.00.
Cabenuva-an injectable formulation of cabotegravir and rilpivirine and the first injectable complete therapy for adults with HIV-1-is now approved.It is administered once a month as two intramuscular injections following a month of treatment with the oral forms of these drugs.
卡布韦酯/利匹韦林注射剂(Cabenuva)是一种卡替拉韦和利匹韦林的注射剂型,也是首款适用于治疗成人 HIV-1 的完整注射疗法。患者在接受该药物的口服剂型治疗一个月后,每月需接受两次肌肉注射。